Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma by Loic Renaud, Juliette Wencel, Arnaud Pagès, Ahmad Al Jijakli, Hannah Moatti, Laurent Quero, Vincent Camus, Pauline Brice

Get full text

P109: One-Day Brentuximab-Bendamustine (120mg/m2) every 21 days is a feasible and safe treatment for relapsed/refractory Hodgkin lymphoma by Hannah Moatti, Marie-Céleste Laroque, Loïc. Renaud, Odonchimeg Ravdan, Charlotte Schmidt-Hieber, Isabelle Madelaine, Roberta Di Blasi, Catherine Thieblemont, Pauline Brice

Get full text

Skin involvement in systemic lymphoma of follicular helper T‐cell origin: A cohort study of 57 patients by Romain Stammler, Maxime Battistella, Julien Calvani, Baptiste Louveau, François Lemonnier, Saskia Ingen‐Housz Oro, Nicolas Ortonne, Jean David Bouaziz, Jacqueline Rivet, Marie‐Dominique Vignon‐Pennamen, David Boutboul, Caroline Ram‐Wolff, Lionel Galicier, Catherine Thieblemont, Pauline Brice, Loïc Renaud, Geraldine Jeudy, Marie Beylot‐Barry, Christian Le Clech, Charlée Nardin, Jean‐Michel Cayuela, Véronique Meignin, Samia Mourah, Martine Bagot, Adèle De Masson, French Study Group on Cutaneous Lymphomas

Get full text

Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5′RACE by Vincent Camus, Mathieu Viennot, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Victor Bobée, Vinciane Rainville, Elodie Bohers, Pierre Sesques, Corinne Haioun, Eric Durot, Michael Bayaram, Cédric Rossi, Laurent Martin, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérôme Paillassa, Olivier Tournilhac, Nicolas Gower, Alexandre Willaume, Chloé Antier, Loïc Renaud, Emilie Lévêque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Philippe Gaulard, Hervé Tilly, Thierry Jo Molina, Alexandra Traverse-Glehen, Marie Donzel, Philippe Ruminy, Fabrice Jardin

Get full text